October 3, 2018 / 5:23 AM / 2 months ago

BRIEF-Novartis licenses three anti-infective programnes to Boston Pharmaceuticals

Oct 3 (Reuters) - Novartis AG:

* NOVARTIS LICENSES THREE NOVEL ANTI-INFECTIVE PROGRAMS TO BOSTON PHARMACEUTICALS

* SAYS CLINICAL AND PRE-CLINICAL STAGE PROGRAMS FOCUSED ON ADDRESSING GROWING NEED FOR NEW TREATMENTS AGAINST DRUG RESISTANT GRAM-NEGATIVE BACTERIA

* SAYS AGREEMENT IS PART OF NOVARTIS STRATEGY TO PARTNER WITH LIKE-MINDED INNOVATORS TO FURTHER DEVELOP NEW MEDICINES TO ADDRESS GLOBAL HEALTH CHALLENGES Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below